12:00 AM
Mar 04, 2013
 |  BC Week In Review  |  Company News  |  Management Tracks

Cellectis management update

Cellectis S.A. (Euronext:ALCLS), Paris, France
Business: Gene/Cell therapy, Genomics...

Read the full 23 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >